Bioventus Inc. (BVS)
NASDAQ · Healthcare
Bioventus Inc. EBITDA 2019–2025
Bioventus Inc. annual/quarterly ebitda history and growth rate from 2019 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Bioventus Inc. ebitda for the quarter ending March 28, 2026 was 19.6 M, a 17.25% increase year-over-year.
- Bioventus Inc. ebitda for the twelve months ending March 28, 2026 was 68.8 M, a 3159.67% decrease year-over-year.
- Bioventus Inc. annual ebitda for 2025 was 101.0 M, a 193.91% increase from 2024.
- Bioventus Inc. annual ebitda for 2024 was 34.4 M, a 241.05% decrease from 2023.
- Bioventus Inc. annual ebitda for 2023 was -24.4 M, a 78.22% decrease from 2022.
- Bioventus Inc. annual ebitda for 2022 was -111.8 M.
EBITDA
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Bioventus Inc. EBITDA — FAQ
Bioventus Inc. (BVS) ebitda over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BVS's ebitda history?
The chart and table above show Bioventus Inc.'s ebitda by year and by quarter, including the growth rate.